Skip to main content
. 2021 Mar;10(3):1541–1552. doi: 10.21037/tau-20-1109

Figure 3.

Figure 3

Overview of some of potential biomarkers recently indicated as possible predictors of ICI response in metastatic UC patients. TMB, tumor mutational burden; PD-L1, programmed death-ligand 1; IFN-γ, interferon-gamma.